Dr. Finn on Regorafenib for the Treatment of Patients With HCC

Name: Dr. Finn on Regorafenib for the Treatment of Patients With HCC
Uploaded: 2016-07-25T19:04:22.000Z
Description: Richard Finn, assistant professor of Medicine at the Geffen School of Medicine, Department of Medicine, Division of Hematology/Oncology at UCLA Jonsson Comprehensive Cancer Center, discusses regorafenib (Stivarga) for the treatment of patients with hepatocelluar carcinoma (HCC).

July 25, 2016

Richard S. Finn, MD

Video

Richard Finn, assistant professor of Medicine at the Geffen School of Medicine, Department of Medicine, Division of Hematology/Oncology at UCLA Jonsson Comprehensive Cancer Center, discusses regorafenib (Stivarga) for the treatment of patients with hepatocelluar carcinoma (HCC).